Dana Farber Cancer Institute: $3.4B Revenue, $2.3B Program Expenses

On the LakeQuality nonprofit efficiency rubric, Dana Farber Cancer Institute pulls an A — the highest available grade. The 87/100 composite reflects a combination of program-focused spending, controlled overhead, and the kind of multi-year financial discipline that grant-makers look for.

Dana Farber Cancer Institute operates at corporate scale — $3.4B in reported 2023 revenue. At over a billion in annual revenue, nonprofits typically run consolidated operations across multiple states or business lines, and the IRS Form 990 reflects a much larger operational footprint than a typical 501(c)(3). Dana Farber Cancer Institute directs 80% of its expenses to programs — above the third-party-rater threshold for an efficient organization.

Five-year revenue trajectory is strongly positive: Dana Farber Cancer Institute has grown materially in real terms, which usually signals successful fundraising and program expansion. CEO compensation is reported as zero in the filing — typical for nonprofits where the chief executive is paid through a related entity (parent system, university, or foundation) rather than the filing organization itself, or for small organizations whose chief is a volunteer or board member. Dana Farber Cancer Institute is in the Medical Research category — public-affairs, civic, and research-policy organizations. The sector includes think tanks, advocacy organizations, and policy-research nonprofits.